Product description

Propofol is a short and rapid-acting general anesthetic with narcotic and sedative properties. It is administered intravenously for anesthesia and sedation during intensive care and is often used in combination with the analgesic Remifentanil.

Comprehensive documentation for drug registration of Propofol can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
2078-54-8 CEP, ASMF EP, USP


Propofol (Anesthetic)

Country availability

Available worldwide

Martin Krb

Contact person

Martin Krb

General Manager

email   phone